Although differences between vehicle- and INCB3284-treated animals in small bowel and colon wet-weight/dry-weight ratios did not reach statistical significance individually ( Fig. 5 , B and C ), wet-weight/dry-weight ratios of all tissues combined were significantly reduced with INCB3284 treatment ( Fig. 5 D ).
← all excerpts
The Chemokine (C-C Motif) Receptor 2 Antagonist INCB3284 Reduces Fluid Requirements and Protects From Hemodynamic Decompensation During Resuscitation From Hemorrhagic Shock.
1
—
—